Corrigendum to “Design, Synthesis, Biological Evaluation, and In Silico Studies of Quinoxaline Derivatives as Potent p38αMAPK Inhibitors”

Similar Items

• Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells
  by: Bayan Zoatier, et al.
  Published: (2025)
• Design, Synthesis, Biological Evaluation, and In Silico Studies of Novel Furo[2,3‐ d ]pyrimidine Derivatives as EGFR Inhibitors With Potential Antitumor Activity
  by: Samar I. Faggal, et al.
  Published: (2025)
• Rational Design, Green Synthesis, and Biological Evaluation of Novel Imidazole Derivatives as Potent EGFR Inhibitors via One‐Pot Four‐Component Reaction
  by: Alaa Muqbil Alsirhani, et al.
  Published: (2025)
• Design, Synthesis, Biological Evaluation, and In Silico Studies of New Nitazoxanide Derivatives: Toward Broad‐Spectrum Antimicrobial Agents
  by: Mahmoud Saleh, et al.
  Published: (2025)
• Exploration of New Dihydroindazole Derivatives as Promising Anti‐TB Agents: Design, Synthesis, In Silico, and Biological Evaluation
  by: Pardeep Kumar, et al.
  Published: (2025)